MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate

PLoS One. 2014 Jun 4;9(6):e98892. doi: 10.1371/journal.pone.0098892. eCollection 2014.

Abstract

Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regulation of neural development and ESC differentiation and specification. Thus, neural differentiation of mESCs in vitro allows investigating the role of miRNAs in chemical-mediated developmental toxicity. We analyzed changes in miRNome and transcriptome during neural differentiation of mESCs exposed to the developmental neurotoxicant sodium valproate (VPA). A total of 110 miRNAs and 377 mRNAs were identified differently expressed in neurally differentiating mESCs upon VPA treatment. Based on miRNA profiling we observed that VPA shifts the lineage specification from neural to myogenic differentiation (upregulation of muscle-abundant miRNAs, mir-206, mir-133a and mir-10a, and downregulation of neural-specific mir-124a, mir-128 and mir-137). These findings were confirmed on the mRNA level and via immunochemistry. Particularly, the expression of myogenic regulatory factors (MRFs) as well as muscle-specific genes (Actc1, calponin, myosin light chain, asporin, decorin) were found elevated, while genes involved in neurogenesis (e.g. Otx1, 2, and Zic3, 4, 5) were repressed. These results were specific for valproate treatment and--based on the following two observations--most likely due to the inhibition of histone deacetylase (HDAC) activity: (i) we did not observe any induction of muscle-specific miRNAs in neurally differentiating mESCs exposed to the unrelated developmental neurotoxicant sodium arsenite; and (ii) the expression of muscle-abundant mir-206 and mir-10a was similarly increased in cells exposed to the structurally different HDAC inhibitor trichostatin A (TSA). Based on our results we conclude that miRNA expression profiling is a suitable molecular endpoint for developmental neurotoxicity. The observed lineage shift into myogenesis, where miRNAs may play an important role, could be one of the developmental neurotoxic mechanisms of VPA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Line
  • Cell Survival / drug effects
  • Cluster Analysis
  • Drug Discovery*
  • Embryonic Stem Cells / cytology
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism
  • GABA Agents / toxicity
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation / drug effects
  • Gene Regulatory Networks
  • Histone Deacetylase Inhibitors / pharmacology
  • In Vitro Techniques*
  • Mice
  • MicroRNAs / genetics*
  • Muscle Development / genetics
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurotoxicity Syndromes / genetics*
  • Neurotoxicity Syndromes / metabolism
  • Reproducibility of Results
  • Signal Transduction / drug effects
  • Time Factors
  • Valproic Acid / toxicity

Substances

  • GABA Agents
  • Histone Deacetylase Inhibitors
  • MicroRNAs
  • Valproic Acid

Grants and funding

This study was financially supported by intramural funding of the German Federal Institute for Risk Assessment (BfR), SFP grant # 1322-458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.